Journal of Chemistry

Journal of Chemistry / 2008 / Article

Open Access

Volume 5 |Article ID 830737 | https://doi.org/10.1155/2008/830737

Kalpana Singh, Peeyush Patel, A. K. Goswami, "Anti-Inflammatory Activity of Hydroxytriazenes and their Vanadium Complexes", Journal of Chemistry, vol. 5, Article ID 830737, 5 pages, 2008. https://doi.org/10.1155/2008/830737

Anti-Inflammatory Activity of Hydroxytriazenes and their Vanadium Complexes

Received27 Mar 2008
Accepted05 Jun 2008

Abstract

The anti-inflammatory activity of hydroxytriazenes as well as their vanadium complexes has been studied using carrageenan induced hind paw oedema method in albino rats (Wister strain). Hydroxytriazenes viz., 3-hydroxy-1,3-diphenyltriazene (HT-1), 3-hydroxy-3-phenyl-1-(4-sulfonamido)phenyl triazene (HT-2), 3-hydroxy-3-p-chlorophenyl-1-(4-sulfonamido) phenyltriazene (HT-3), 3-hydroxy-3-m-chlorophenyl-1-(4-sulfonamido)phenyltriazene (HT-4)(HT-4) and their respective vanadium complexes C-1, C-2, C-3 and C-4 have been synthesized using standard methods, purified, characterized and used for studying their anti-inflammatory activities. The hind paw oedema was produced by subplanter injection of carrageenan and the paw volume was measured plethysmographically after 0.5, 1, 2, 3 and 5 h. The animals were given HT-1, HT-2, HT-3 and HT-4 and also vanadium complexes C-1, C-2, C-3 and C-4 dissolved in DMSO (at dose 5 mg/Kg body weight). Diclofenac sodium (5 mg/kg) was used as a standard drug. The standard drug shows maximum inibition up to 1h as 81.73% which goes on increasing up to 3h (88.94%) but further reduces to 74.93% at the end of 5 h. The test compounds i.e. both ligands as well as their metal complexes show maximum percent inhibition only up to 1h. after which the efficacy reduces. Thus it can be said that both ligands as well as their vanadium complexes show very significant anti-inflammatory activity up to 1h which is comparable to standard drug.

Copyright © 2008 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views497
Downloads599
Citations

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.